Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2018
US$ 3,500.00
... Wilms Tumor Protein (WT33 or WT1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2018
65 pages
Polyarticular Juvenile Idiopathic Arthritis (PJIA) - Pipeline Review, H1 2018
US$ 2,000.00
... Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Polyarticular Juvenile Idiopathic Arthritis (PJIA) and features dormant and discontinued projects. The guide covers therapeutics under Development ...
May 2018
79 pages
Toll Like Receptor 3 (CD283 or TLR3) - Pipeline Review, H1 2018
US$ 3,500.00
... Toll Like Receptor 3 (CD283 or TLR3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2018
67 pages
Toll Like Receptor 8 (CD288 or TLR8) - Pipeline Review, H1 2018
US$ 3,500.00
... Toll Like Receptor 8 (CD288 or TLR8) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2018
75 pages
Q Fever - Pipeline Review, H1 2018
US$ 2,000.00
... . The Q Fever (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Q Fever and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2018
38 pages
Interleukin 1 (IL1) - Pipeline Review, H1 2018
US$ 3,500.00
... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Interleukin 1 (IL1) development landscape Develop and design in-licensing and ...
May 2018
106 pages
Radiation Injury - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Radiation Injury (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Radiation Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
April 2018
46 pages
Premenstrual Syndrome - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Premenstrual Syndrome (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Premenstrual Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2018
32 pages
Beta Nerve Growth Factor (Beta NGF or NGF) - Pipeline Review, H1 2018
US$ 3,500.00
... Beta Nerve Growth Factor (Beta NGF or NGF) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
April 2018
52 pages
Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H1 2018
US$ 3,500.00
... Transforming Growth Factor Beta 1 (TGFB1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
April 2018
69 pages
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2018
US$ 2,000.00
... . The Thrombotic Thrombocytopenic Purpura (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Thrombotic Thrombocytopenic Purpura and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
April 2018
61 pages
